SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Ibon Eguíluz-Gracia, Teresa Robledo-Echarren, Ricardo Suárez-Fernández, Montserrat Fernández-Rivas, Silvia Sánchez-Ramón, Omalizumab for the treatment of atopic dermatitis, Clinical Investigation, 2015, 5, 2, 121

    CrossRef

  2. 2
    Z. Song, X. Deng, W. Chen, J. Xu, S. Chen, H. Zhong, F. Hao, Toll-like receptor 2 agonist Pam3CSK4 up-regulates FcεRI receptor expression on monocytes from patients with severe extrinsic atopic dermatitis, Journal of the European Academy of Dermatology and Venereology, 2015, 29, 6
  3. 3
    D. Simon, T. Bieber, Systemic therapy for atopic dermatitis, Allergy, 2014, 69, 1
  4. 4
    C. Schlapbach, D. Simon, Update on skin allergy, Allergy, 2014, 69, 12
  5. 5
    K. Eyerich, N. Novak, Immunology of atopic eczema: overcoming the Th1/Th2 paradigm, Allergy, 2013, 68, 8
  6. 6
    T. Bieber, Many ways lead to Rome: a glance at the multiple immunological pathways underlying atopic dermatitis, Allergy, 2013, 68, 8